Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines

Feline oral squamous cell carcinoma (FOSCC) is a malignant tumor characterized by an aggressive behavior and poor prognosis, for which no fully effective therapies are available. Studies of comparative oncology suggest that epidermal growth factor receptor (EGFR) may be a therapeutic target in FOSCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Altamura, Gennaro, Borzacchiello, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712204/
https://www.ncbi.nlm.nih.gov/pubmed/36467642
http://dx.doi.org/10.3389/fvets.2022.1040552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712204/
https://www.ncbi.nlm.nih.gov/pubmed/36467642
http://dx.doi.org/10.3389/fvets.2022.1040552

Ejemplares similares